News
4h
Irish Examiner on MSNCouple push for drug that slows down muscular dystrophy to be made available in IrelandThe drug Givinostat has been brought into parts of Britain. We want that too, but we need the government to pay for it,' said Una Ennis ...
One visit to Virginia Peninsula Community College’s Historic Triangle Campus last summer eased any concerns they might have had. Soon after entering the building, Nicholas and his mother, Liz, were ...
FDA has indicated that an Advisory Committee meeting is not required at this timeIn-person late-cycle review meeting ...
New consensus guidelines outline best practices for orthopedic management in Duchenne muscular dystrophy, focusing on ...
Sarepta Therapeutics Inc. misled investors about the safety and prospects for one of its Duchenne muscular dystrophy ...
Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS® ...
Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage company focused on delivering functional improvement for people living with genetically driven neuromuscular diseases, today announced it has ...
5d
MedPage Today on MSNFDA Probes Gene Therapy After Two DeathsDuchenne muscular dystrophy is characterized by a mutation in the DMD gene that leads to a lack of dystrophin and muscle loss ...
The U.S. Food and Drug Administration said on Tuesday that it is investigating reports of two deaths due to acute liver ...
Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage company focused on delivering functional improvement for people living with genetically driven neuromuscular diseases, today announced that it ...
Although only living in the Berkshires for a few years, Evan Butts has already ingrained himself into the community. A server ...
The FDA found that data from a single Phase II study were “insufficient” to justify an accelerated approval review for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results